Tag Archives: pharma

Finding the win-win solutions to health care challenges

There isn’t a single cure to address all of the challenges facing our health system, but there is a common goal. We all want a health system that treats patients compassionately, allocates resources efficiently, and provides quality care to those who need it — all without bankrupting ourselves or future generations. Too often we pursue […]
Read More »

ISPOR, Optum and the Power of Real-World Data

The life sciences industry is facing unprecedented opportunities and challenges, and I’m excited. We’re entering new and diverse markets, unlike any we’ve experienced before, while at the same time the dynamics in existing markets are becoming more complex due to health care transformation efforts.

What’s the “Best” Data?–The Data That Can Answer the Question!

In a previous post by my colleague Dr. Aylin Altan Riedel, she presented an overview of Analyze This!, an educational symposium sponsored by Optum Life Sciences at the 18th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting. I’m pleased to be a part of this panel discussion focused on getting the […]
Read More »

Analyze This! ISPOR panel to discuss Big Data, The Cloud and Real World Evidence

Each year at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, the Optum Life Sciences group hosts an educational symposium before the attending global researchers and thought leaders. At this year’s 18th ISPOR gathering, I’m pleased to moderate an important educational symposium to be held tomorrow titled, “Analyze This! Getting the […]
Read More »

ISPOR: Focusing on the Patient

For the past 17 years, attendance at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting has grown from under 500 in attendance at the first conference held in 1996 to an expected turnout of more than 3,000 during the May 18-22, 2013 meeting in New Orleans.

Do You Hate to be Late? Most People Do

In most every aspect of our lives, it pays to be on time. This is especially true for pharmaceutical companies under pressure to complete clinical trials quickly and effectively so they can bring new drugs to market sooner. Unfortunately, clinical trials often are subject to costly delays, caused by the challenges inherent in finding the […]
Read More »